Guardian Pharmacy Services (GRDN) Competitors

Guardian Pharmacy Services logo
$38.74 +0.41 (+1.08%)
Closing price 06/25/2026 03:59 PM Eastern
Extended Trading
$38.88 +0.14 (+0.35%)
As of 05:56 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GRDN vs. GAP, CHWY, ACI, VIPS, and VSXY

Should you buy Guardian Pharmacy Services stock or one of its competitors? MarketBeat compares Guardian Pharmacy Services with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Guardian Pharmacy Services include GAP (GAP), Chewy (CHWY), Albertsons Companies (ACI), Vipshop (VIPS), and Victoria's Secret & Co. (VSXY). These companies are all part of the "retail" industry.

How does Guardian Pharmacy Services compare to GAP?

GAP (NYSE:GAP) and Guardian Pharmacy Services (NYSE:GRDN) are both retail companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings.

GAP has a net margin of 6.25% compared to Guardian Pharmacy Services' net margin of 3.64%. Guardian Pharmacy Services' return on equity of 30.72% beat GAP's return on equity.

Company Net Margins Return on Equity Return on Assets
GAP6.25% 21.13% 6.23%
Guardian Pharmacy Services 3.64%30.72%15.99%

GAP currently has a consensus price target of $28.71, indicating a potential upside of 42.40%. Guardian Pharmacy Services has a consensus price target of $42.83, indicating a potential upside of 10.55%. Given GAP's higher probable upside, equities research analysts clearly believe GAP is more favorable than Guardian Pharmacy Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GAP
0 Sell rating(s)
6 Hold rating(s)
10 Buy rating(s)
2 Strong Buy rating(s)
2.78
Guardian Pharmacy Services
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78

GAP has a beta of 2.03, meaning that its share price is 103% more volatile than the broader market. Comparatively, Guardian Pharmacy Services has a beta of 0.08, meaning that its share price is 92% less volatile than the broader market.

GAP has higher revenue and earnings than Guardian Pharmacy Services. GAP is trading at a lower price-to-earnings ratio than Guardian Pharmacy Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GAP$15.40B0.47$816M$2.547.94
Guardian Pharmacy Services$1.45B1.33$49.22M$0.8346.68

In the previous week, GAP had 8 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 10 mentions for GAP and 2 mentions for Guardian Pharmacy Services. GAP's average media sentiment score of 0.77 beat Guardian Pharmacy Services' score of 0.38 indicating that GAP is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GAP
5 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Guardian Pharmacy Services
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

58.8% of GAP shares are owned by institutional investors. 31.0% of GAP shares are owned by insiders. Comparatively, 33.0% of Guardian Pharmacy Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

GAP beats Guardian Pharmacy Services on 11 of the 16 factors compared between the two stocks.

How does Guardian Pharmacy Services compare to Chewy?

Guardian Pharmacy Services (NYSE:GRDN) and Chewy (NYSE:CHWY) are both retail companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership.

Chewy has higher revenue and earnings than Guardian Pharmacy Services. Chewy is trading at a lower price-to-earnings ratio than Guardian Pharmacy Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardian Pharmacy Services$1.45B1.33$49.22M$0.8346.68
Chewy$12.60B0.59$222.80M$0.6030.22

In the previous week, Chewy had 16 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 18 mentions for Chewy and 2 mentions for Guardian Pharmacy Services. Chewy's average media sentiment score of 0.92 beat Guardian Pharmacy Services' score of 0.38 indicating that Chewy is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardian Pharmacy Services
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Chewy
6 Very Positive mention(s)
9 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Guardian Pharmacy Services has a beta of 0.08, meaning that its stock price is 92% less volatile than the broader market. Comparatively, Chewy has a beta of 1.44, meaning that its stock price is 44% more volatile than the broader market.

Guardian Pharmacy Services presently has a consensus price target of $42.83, indicating a potential upside of 10.55%. Chewy has a consensus price target of $32.05, indicating a potential upside of 76.75%. Given Chewy's stronger consensus rating and higher probable upside, analysts plainly believe Chewy is more favorable than Guardian Pharmacy Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardian Pharmacy Services
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78
Chewy
0 Sell rating(s)
6 Hold rating(s)
18 Buy rating(s)
1 Strong Buy rating(s)
2.80

93.1% of Chewy shares are owned by institutional investors. 33.0% of Guardian Pharmacy Services shares are owned by insiders. Comparatively, 0.3% of Chewy shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Guardian Pharmacy Services has a net margin of 3.64% compared to Chewy's net margin of 1.99%. Chewy's return on equity of 60.02% beat Guardian Pharmacy Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Guardian Pharmacy Services3.64% 30.72% 15.99%
Chewy 1.99%60.02%8.17%

Summary

Chewy beats Guardian Pharmacy Services on 11 of the 17 factors compared between the two stocks.

How does Guardian Pharmacy Services compare to Albertsons Companies?

Albertsons Companies (NYSE:ACI) and Guardian Pharmacy Services (NYSE:GRDN) are both retail companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

Albertsons Companies has higher revenue and earnings than Guardian Pharmacy Services. Albertsons Companies is trading at a lower price-to-earnings ratio than Guardian Pharmacy Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Albertsons Companies$83.17B0.08$217.40M$0.3242.90
Guardian Pharmacy Services$1.45B1.33$49.22M$0.8346.68

Albertsons Companies has a beta of 0.4, suggesting that its share price is 60% less volatile than the broader market. Comparatively, Guardian Pharmacy Services has a beta of 0.08, suggesting that its share price is 92% less volatile than the broader market.

71.4% of Albertsons Companies shares are held by institutional investors. 1.4% of Albertsons Companies shares are held by insiders. Comparatively, 33.0% of Guardian Pharmacy Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Albertsons Companies had 8 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 10 mentions for Albertsons Companies and 2 mentions for Guardian Pharmacy Services. Albertsons Companies' average media sentiment score of 0.82 beat Guardian Pharmacy Services' score of 0.38 indicating that Albertsons Companies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Albertsons Companies
4 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Guardian Pharmacy Services
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Albertsons Companies presently has a consensus target price of $21.31, indicating a potential upside of 55.21%. Guardian Pharmacy Services has a consensus target price of $42.83, indicating a potential upside of 10.55%. Given Albertsons Companies' higher probable upside, analysts clearly believe Albertsons Companies is more favorable than Guardian Pharmacy Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Albertsons Companies
3 Sell rating(s)
4 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.41
Guardian Pharmacy Services
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78

Guardian Pharmacy Services has a net margin of 3.64% compared to Albertsons Companies' net margin of 0.26%. Albertsons Companies' return on equity of 42.75% beat Guardian Pharmacy Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Albertsons Companies0.26% 42.75% 4.24%
Guardian Pharmacy Services 3.64%30.72%15.99%

Summary

Albertsons Companies beats Guardian Pharmacy Services on 9 of the 16 factors compared between the two stocks.

How does Guardian Pharmacy Services compare to Vipshop?

Guardian Pharmacy Services (NYSE:GRDN) and Vipshop (NYSE:VIPS) are both retail companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, media sentiment and analyst recommendations.

48.8% of Vipshop shares are owned by institutional investors. 33.0% of Guardian Pharmacy Services shares are owned by insiders. Comparatively, 29.5% of Vipshop shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Vipshop has a net margin of 7.08% compared to Guardian Pharmacy Services' net margin of 3.64%. Guardian Pharmacy Services' return on equity of 30.72% beat Vipshop's return on equity.

Company Net Margins Return on Equity Return on Assets
Guardian Pharmacy Services3.64% 30.72% 15.99%
Vipshop 7.08%16.90%9.47%

Guardian Pharmacy Services presently has a consensus price target of $42.83, indicating a potential upside of 10.55%. Vipshop has a consensus price target of $20.20, indicating a potential upside of 55.71%. Given Vipshop's higher possible upside, analysts plainly believe Vipshop is more favorable than Guardian Pharmacy Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardian Pharmacy Services
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78
Vipshop
1 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.50

In the previous week, Guardian Pharmacy Services had 1 more articles in the media than Vipshop. MarketBeat recorded 2 mentions for Guardian Pharmacy Services and 1 mentions for Vipshop. Guardian Pharmacy Services' average media sentiment score of 0.38 beat Vipshop's score of 0.07 indicating that Guardian Pharmacy Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardian Pharmacy Services
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Vipshop
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Guardian Pharmacy Services has a beta of 0.08, indicating that its stock price is 92% less volatile than the broader market. Comparatively, Vipshop has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market.

Vipshop has higher revenue and earnings than Guardian Pharmacy Services. Vipshop is trading at a lower price-to-earnings ratio than Guardian Pharmacy Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardian Pharmacy Services$1.45B1.33$49.22M$0.8346.68
Vipshop$106.23B0.06$1.04B$2.136.09

Summary

Guardian Pharmacy Services beats Vipshop on 9 of the 17 factors compared between the two stocks.

How does Guardian Pharmacy Services compare to Victoria's Secret & Co.?

Guardian Pharmacy Services (NYSE:GRDN) and Victoria's Secret & Co. (NYSE:VSXY) are both retail companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk.

Guardian Pharmacy Services presently has a consensus target price of $42.83, suggesting a potential upside of 10.55%. Victoria's Secret & Co. has a consensus target price of $82.60, suggesting a potential downside of 0.18%. Given Guardian Pharmacy Services' stronger consensus rating and higher possible upside, equities research analysts plainly believe Guardian Pharmacy Services is more favorable than Victoria's Secret & Co..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardian Pharmacy Services
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78
Victoria's Secret & Co.
0 Sell rating(s)
6 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.62

Guardian Pharmacy Services has a net margin of 3.64% compared to Victoria's Secret & Co.'s net margin of 3.11%. Victoria's Secret & Co.'s return on equity of 38.03% beat Guardian Pharmacy Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Guardian Pharmacy Services3.64% 30.72% 15.99%
Victoria's Secret & Co. 3.11%38.03%6.10%

90.3% of Victoria's Secret & Co. shares are held by institutional investors. 33.0% of Guardian Pharmacy Services shares are held by company insiders. Comparatively, 0.5% of Victoria's Secret & Co. shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Victoria's Secret & Co. has higher revenue and earnings than Guardian Pharmacy Services. Victoria's Secret & Co. is trading at a lower price-to-earnings ratio than Guardian Pharmacy Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardian Pharmacy Services$1.45B1.33$49.22M$0.8346.68
Victoria's Secret & Co.$6.55B1.00$161M$1.8644.49

In the previous week, Guardian Pharmacy Services had 2 more articles in the media than Victoria's Secret & Co.. MarketBeat recorded 2 mentions for Guardian Pharmacy Services and 0 mentions for Victoria's Secret & Co.. Victoria's Secret & Co.'s average media sentiment score of 1.00 beat Guardian Pharmacy Services' score of 0.38 indicating that Victoria's Secret & Co. is being referred to more favorably in the news media.

Company Overall Sentiment
Guardian Pharmacy Services Neutral
Victoria's Secret & Co. Positive

Guardian Pharmacy Services has a beta of 0.08, suggesting that its share price is 92% less volatile than the broader market. Comparatively, Victoria's Secret & Co. has a beta of 2.16, suggesting that its share price is 116% more volatile than the broader market.

Summary

Guardian Pharmacy Services beats Victoria's Secret & Co. on 9 of the 17 factors compared between the two stocks.

Get Guardian Pharmacy Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRDN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GRDN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GRDN vs. The Competition

MetricGuardian Pharmacy ServicesMED IndustryMedical SectorNYSE Exchange
Market Cap$1.91B$3.01B$6.61B$23.16B
Dividend YieldN/A1.77%2.67%4.06%
P/E Ratio46.6818.8225.7631.50
Price / Sales1.33329.66558.1620.78
Price / Cash30.4356.5346.3324.53
Price / Book11.264.1210.714.69
Net Income$49.22M$64.45M$3.57B$1.07B
7 Day Performance-9.14%0.08%0.79%-0.15%
1 Month Performance0.45%-0.44%0.21%-0.18%
1 Year Performance83.17%23.45%30.83%23.79%

Guardian Pharmacy Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GRDN
Guardian Pharmacy Services
2.1792 of 5 stars
$38.74
+1.1%
$42.83
+10.6%
+90.7%$1.91B$1.45B46.683,600
GAP
GAP
4.939 of 5 stars
$20.90
+2.2%
$28.71
+37.4%
-6.0%$7.36B$15.37B8.2379,000
CHWY
Chewy
4.8885 of 5 stars
$19.01
+6.5%
$32.05
+68.6%
-57.5%$7.31B$12.60B31.6818,000
ACI
Albertsons Companies
4.1867 of 5 stars
$14.15
+1.8%
$21.31
+50.5%
-35.5%$6.81B$83.17B44.23280,000
VIPS
Vipshop
4.9602 of 5 stars
$13.39
+1.7%
$20.20
+50.8%
-12.4%$6.31B$15.15B6.2915,145

Related Companies and Tools


This page (NYSE:GRDN) was last updated on 6/26/2026 by MarketBeat.com Staff.
From Our Partners